Marco Anelli
Marco Anelli is R&D Director of ProductLife Group.
Articles
Understanding the Potential of Artificial Intelligence Across the Pharmaceutical Lifecycle
August 10th 2017Artificial intelligence offers a number of opportunities in pharmaceutical drug development and manufacturing, but there are barriers to overcome, notably around how well and how quickly the regulatory environment can adapt and keep pace with to the rapid changes.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 12th 2024 | Updated: November 29th 2024
AAPS PharmSci 360: Challenges in Peptide-Based Drugs
Published: November 13th 2024 | Updated: November 29th 2024
Risk-Based Development Supporting Process Qualification for Spray-Dried Dispersion
Published: November 22nd 2024 | Updated: November 29th 2024
Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice
Published: November 22nd 2024 | Updated: November 29th 2024
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
